115 related articles for article (PubMed ID: 31038390)
1. Novel Genomic Biomarker Candidates for Cervical Cancer As Identified by Differential Co-Expression Network Analysis.
Kori M; Gov E; Arga KY
OMICS; 2019 May; 23(5):261-273. PubMed ID: 31038390
[TBL] [Abstract][Full Text] [Related]
2. Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
Wang J; Yi Y; Chen Y; Xiong Y; Zhang W
Int J Med Sci; 2020; 17(15):2362-2372. PubMed ID: 32922202
[TBL] [Abstract][Full Text] [Related]
3. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract][Full Text] [Related]
4. In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment.
van Dam PA; van Dam PJ; Rolfo C; Giallombardo M; van Berckelaer C; Trinh XB; Altintas S; Huizing M; Papadimitriou K; Tjalma WA; van Laere S
Oncotarget; 2016 Jan; 7(3):2780-95. PubMed ID: 26701206
[TBL] [Abstract][Full Text] [Related]
5. Interactive bioinformatics analysis for the screening of hub genes and molecular docking of phytochemicals present in kitchen spices to inhibit CDK1 in cervical cancer.
Vaghasia H; Sakaria S; Prajapati J; Saraf M; Rawal RM
Comput Biol Med; 2022 Oct; 149():105994. PubMed ID: 36103746
[TBL] [Abstract][Full Text] [Related]
6. Predicting Hub Genes Associated with Cervical Cancer through Gene Co-Expression Networks.
Deng SP; Zhu L; Huang DS
IEEE/ACM Trans Comput Biol Bioinform; 2016; 13(1):27-35. PubMed ID: 26415208
[TBL] [Abstract][Full Text] [Related]
7. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Cancer Differential Interactome and Network Entropy Analysis Reveal New Candidate Biomarkers.
Ayyildiz D; Gov E; Sinha R; Arga KY
OMICS; 2017 May; 21(5):285-294. PubMed ID: 28375712
[TBL] [Abstract][Full Text] [Related]
9. A 19-Gene Signature of Serous Ovarian Cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine.
Kori M; Demirtas TY; Comertpay B; Arga KY; Sinha R; Gov E
OMICS; 2024 Feb; 28(2):90-101. PubMed ID: 38320250
[TBL] [Abstract][Full Text] [Related]
10. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
12. Identification of
Zhao S; Yu M
DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
[TBL] [Abstract][Full Text] [Related]
13. Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
Qin S; Gao Y; Yang Y; Zhang L; Zhang T; Yu J; Shi C
Gynecol Obstet Invest; 2019; 84(4):350-359. PubMed ID: 30625468
[TBL] [Abstract][Full Text] [Related]
14. OScc: an online survival analysis web server to evaluate the prognostic value of biomarkers in cervical cancer.
Wang Q; Zhang L; Yan Z; Xie L; An Y; Li H; Han Y; Zhang G; Dong H; Zheng H; Zhu W; Li Y; Wang Y; Guo X
Future Oncol; 2019 Nov; 15(32):3693-3699. PubMed ID: 31512935
[No Abstract] [Full Text] [Related]
15. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
16. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
17. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
18. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
[TBL] [Abstract][Full Text] [Related]
19. Identification of Hub Genes Using Co-Expression Network Analysis in Breast Cancer as a Tool to Predict Different Stages.
Fu Y; Zhou QZ; Zhang XL; Wang ZZ; Wang P
Med Sci Monit; 2019 Nov; 25():8873-8890. PubMed ID: 31758680
[TBL] [Abstract][Full Text] [Related]
20. Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer.
Gov E; Arga KY
Sci Rep; 2017 Jul; 7(1):4996. PubMed ID: 28694494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
